These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 29388767)
1. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs. Webb CT; Lupták A Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767 [TBL] [Abstract][Full Text] [Related]
6. In vitro selection analysis of trans-acting HDV ribozyme. Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579 [TBL] [Abstract][Full Text] [Related]
7. HDV family of self-cleaving ribozymes. Riccitelli N; Lupták A Prog Mol Biol Transl Sci; 2013; 120():123-71. PubMed ID: 24156943 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study on HDV ribozyme in vitro cleaving the HBV derived RNA fragment]. Pan GJ; Han JX Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):149-52. PubMed ID: 12869998 [TBL] [Abstract][Full Text] [Related]
9. Topological constraints of structural elements in regulation of catalytic activity in HDV-like self-cleaving ribozymes. Webb CH; Nguyen D; Myszka M; Lupták A Sci Rep; 2016 Jun; 6():28179. PubMed ID: 27302490 [TBL] [Abstract][Full Text] [Related]
10. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes. Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117 [TBL] [Abstract][Full Text] [Related]
11. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses. Tanner NK; Schaff S; Thill G; Petit-Koskas E; Crain-Denoyelle AM; Westhof E Curr Biol; 1994 Jun; 4(6):488-98. PubMed ID: 7922369 [TBL] [Abstract][Full Text] [Related]
12. Catalytic core structure of the trans-acting HDV ribozyme is subtly influenced by sequence variation outside the core. Gondert ME; Tinsley RA; Rueda D; Walter NG Biochemistry; 2006 Jun; 45(24):7563-73. PubMed ID: 16768452 [TBL] [Abstract][Full Text] [Related]
13. Catalytic strategies of the hepatitis delta virus ribozymes. Shih IH; Been MD Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114 [TBL] [Abstract][Full Text] [Related]
14. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots. Chadalavada DM; Senchak SE; Bevilacqua PC J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009 [TBL] [Abstract][Full Text] [Related]
15. Activity of HDV ribozymes to trans-cleave HCV RNA. Yu YC; Mao Q; Gu CH; Li QF; Wang YM World J Gastroenterol; 2002 Aug; 8(4):694-8. PubMed ID: 12174380 [TBL] [Abstract][Full Text] [Related]
16. An AU at the first base pair of helix 3 elevates the catalytic activity of hepatitis delta virus ribozymes. Huang ZS; Ping YH; Wu HN FEBS Lett; 1997 Aug; 413(2):299-303. PubMed ID: 9280301 [TBL] [Abstract][Full Text] [Related]
17. Unbiased in vitro selection reveals the unique character of the self-cleaving antigenomic HDV RNA sequence. Nehdi A; Perreault JP Nucleic Acids Res; 2006; 34(2):584-92. PubMed ID: 16432262 [TBL] [Abstract][Full Text] [Related]
18. Local conformational changes in the catalytic core of the trans-acting hepatitis delta virus ribozyme accompany catalysis. Harris DA; Rueda D; Walter NG Biochemistry; 2002 Oct; 41(40):12051-61. PubMed ID: 12356305 [TBL] [Abstract][Full Text] [Related]